Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

29.66 -0.42 (-1.41%)

Streaming Delayed Price Updated: 11:36 AM EDT, Jun 22, 2026 Add to My Watchlist

Price and Volume

Volume	504,176
Open	29.91
Bid (Size)	29.65 (500)
Ask (Size)	29.66 (700)
Prev. Close	30.08
Today's Range	29.53 - 29.94
52wk Range	28.80 - 38.79
Shares Outstanding	N/A
Dividend Yield	3.25%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

June 09, 2026

Issued on behalf of Conexeu Sciences Inc.

From Equity Insider

Via GlobeNewswire

Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty

June 08, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Performance

YTD	-9.8%	-9.8%
1 Month	-2.9%	-2.9%
3 Month	-7.2%	-7.2%
6 Month	-10.5%	-10.5%
1 Year	+1.7%	+1.7%

More News

Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact

June 01, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

A Reno Biotech Just Rang the Nasdaq Bell — Here’s Why the Whole Regenerative-Medicine Tape Is Worth Watching

May 22, 2026

From World Street Intelligence

Via GlobeNewswire

Smith & Nephew (NYSE:SNN) Qualifies as a Quality Investment Through the Caviar Cruise Screen ↗

April 24, 2026

Via Chartmill

Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing ↗

April 02, 2026

Via Chartmill

Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026

May 05, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years

April 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,*

April 09, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention

March 10, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026

March 03, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026

March 02, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons

February 24, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew signs distribution agreement with SI-BONE

February 23, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair

January 21, 2026

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices ↗

November 29, 2025

Via Chartmill

Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT

October 27, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

UFC® and Smith+Nephew announce multi-year extension of partnership

October 22, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Organogenesis Holdings (ORGO) Battles Headwinds: Can This Regenerative Medicine Innovator Stage a Comeback?

October 17, 2025

Via MarketMinute

Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant

October 09, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention

October 03, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty

October 01, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗

September 25, 2025

Via Benzinga

Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant

September 11, 2025

From Smith & Nephew UK Ltd

Via GlobeNewswire

What Does the Market Think About Smith & Nephew? ↗

September 03, 2025

Via Benzinga

Frequently Asked Questions

Is Smith & Nephew SNATS, Inc. Common Stock publicly traded?

Yes, Smith & Nephew SNATS, Inc. Common Stock is publicly traded.

What exchange does Smith & Nephew SNATS, Inc. Common Stock trade on?

Smith & Nephew SNATS, Inc. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Smith & Nephew SNATS, Inc. Common Stock?

The ticker symbol for Smith & Nephew SNATS, Inc. Common Stock is SNN on the New York Stock Exchange

What is the current price of Smith & Nephew SNATS, Inc. Common Stock?

The current price of Smith & Nephew SNATS, Inc. Common Stock is 29.66

When was Smith & Nephew SNATS, Inc. Common Stock last traded?

The last trade of Smith & Nephew SNATS, Inc. Common Stock was at 06/22/26 11:36 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.